Post-pandemic Era Global Gaucher Disease (GD) Drugs Market Size, Trends and Opportunties 2022
- Category: Pharma & Healthcare
- Published Date: Jan 2022
- Publisher: GRD Survey
- Pages: 118
This report provides an overview of current global Gaucher Disease (GD) Drugs market based on segmented Types, Applications and key regions. It focuses on major driving factors and inhibitors that affect the market and explains current competitive landscape. Global and regional leading players in the Gaucher Disease (GD) Drugs industry are profiled in a detailed way, with sales data and market share info presented. This report forecasts global and regional market size for major economies such as North America, Europe, China and Japan. According to this report, the global Gaucher Disease (GD) Drugs market is estimated at $ million in 2021, and projected to grow at a CAGR of % to $ million by 2028.
Segmented by Type
Enzyme Replacement Therapy
Substrate Reduction Therapy
Segmented by Application
Non-neuronopathic Gaucher Disease
Neuronopathic Gaucher Disease
Segmented by Region/Country
North America
Europe
China
Japan
Asia Other
Key manufacturers included in this survey
Shire
Sanofi
Pfizer (Protalix)
ISU ABXIS
Actelion Pharma
Table of Contents
1 Product Introduction and Overview
1.1 Product Definition
1.2 Product Specification
1.3 Global Market Overview
1.3.1 Global Gaucher Disease (GD) Drugs Market Status and Forecast (2017-2028)
1.3.2 Global Gaucher Disease (GD) Drugs Sales Value CAGR by Region
1.4 Market Drivers, Inhibitors
1.4.1 Market Drivers
1.4.2 Market Inhibitors
1.4.3 COVID-19 Impact Analysis
2 Global Gaucher Disease (GD) Drugs Supply by Company
2.1 Global Gaucher Disease (GD) Drugs Sales Volume by Company
2.2 Global Gaucher Disease (GD) Drugs Sales Value by Company
2.3 Global Gaucher Disease (GD) Drugs Price by Company
2.4 Gaucher Disease (GD) Drugs Production Location and Sales Area of Main Manufacturers
2.5 Trend of Concentration Rate
3 Global and Regional Gaucher Disease (GD) Drugs Market Status by Type
3.1 Gaucher Disease (GD) Drugs Type Introduction
3.1.1 Enzyme Replacement Therapy
3.1.2 Substrate Reduction Therapy
3.2 Global Gaucher Disease (GD) Drugs Market by Type
3.2.1 Global Gaucher Disease (GD) Drugs Sales Volume by Type (2017-2022)
3.2.2 Global Gaucher Disease (GD) Drugs Sales Value by Type (2017-2022)
3.2.3 Global Gaucher Disease (GD) Drugs Price by Type (2017-2022)
3.3 North America: by Type
3.4 Europe: by Type
3.5 China: by Type
3.6 Japan: by Type
3.7 Asia Other: by Type
4 Global and Regional Gaucher Disease (GD) Drugs Market Status by Application
4.1 Gaucher Disease (GD) Drugs Segment by Application
4.1.1 Non-neuronopathic Gaucher Disease
4.1.2 Neuronopathic Gaucher Disease
4.2 Global Gaucher Disease (GD) Drugs Market by Application
4.2.1 Global Gaucher Disease (GD) Drugs Sales Volume by Application (2017-2022)
4.2.2 Global Gaucher Disease (GD) Drugs Sales Value by Application (2017-2022)
4.2.3 Global Gaucher Disease (GD) Drugs Price by Application (2017-2022)
4.3 North America: by Application
4.4 Europe: by Application
4.5 China: by Application
4.6 Japan: by Application
4.7 Asia Other: by Application
5 Global Gaucher Disease (GD) Drugs Market Status by Region
5.1 Global Gaucher Disease (GD) Drugs Market by Region/Country
5.1.1 Global Gaucher Disease (GD) Drugs Sales Volume by Region/Country
5.1.2 Global Gaucher Disease (GD) Drugs Sales Value by Region/Country
5.2 North America Gaucher Disease (GD) Drugs Market Status
5.3 Europe Gaucher Disease (GD) Drugs Market Status
5.4 China Gaucher Disease (GD) Drugs Market Status
5.5 Japan Gaucher Disease (GD) Drugs Market Status
5.6 Asia Other Gaucher Disease (GD) Drugs Market Status
6 Sales Channel, Distributors and Buyers
6.1 Sales Channel
6.1.1 Direct Sales
6.1.2 Channel Sales
6.2 Gaucher Disease (GD) Drugs Distributors
6.3 Gaucher Disease (GD) Drugs Buyers
7 Global Gaucher Disease (GD) Drugs Market Forecast by Type and by Application
7.1 Global Gaucher Disease (GD) Drugs Sales Volume and Sales Value Forecast (2023-2028)
7.2 Global Gaucher Disease (GD) Drugs Forecast by Type
7.2.1 Global Gaucher Disease (GD) Drugs Sales Volume Forecast by Type
7.2.2 Global Gaucher Disease (GD) Drugs Sales Value Forecast by Type
7.2.3 Global Gaucher Disease (GD) Drugs Price Forecast by Type
7.3 Global Gaucher Disease (GD) Drugs Forecast by Application
7.3.1 Global Gaucher Disease (GD) Drugs Sales Volume Forecast by Application
7.3.2 Global Gaucher Disease (GD) Drugs Sales Value Forecast by Application
7.3.3 Global Gaucher Disease (GD) Drugs Price Forecast by Application
8 Global Gaucher Disease (GD) Drugs Market Forecast by Region/Country
8.1 Global Gaucher Disease (GD) Drugs Market Forecast by Region (2023-2028)
8.1.1 Global Gaucher Disease (GD) Drugs Sales Volume Forecast by Region (2023-2028)
8.1.2 Global Gaucher Disease (GD) Drugs Sales Value Forecast by Region (2023-2028)
8.2 North America Market Forecast
8.3 Europe Market Forecast
8.4 China Market Forecast
8.5 Japan Market Forecast
8.6 Asia Other Market Forecast
9 Key Participants Company Information
9.1 Shire
9.1.1 Company Information
9.1.2 Gaucher Disease (GD) Drugs Product Introduction
9.1.3 Shire
Gaucher Disease (GD) Drugs Sales Volume, Price, Sales Value and Gross Margin (2020-2022)
9.1.4 Contact Information
9.2 Sanofi
9.2.1 Company Information
9.2.2 Gaucher Disease (GD) Drugs Product Introduction
9.2.3 Sanofi
Gaucher Disease (GD) Drugs Sales Volume, Price, Sales Value and Gross Margin (2020-2022)
9.2.4 Contact Information
9.3 Pfizer (Protalix)
9.3.1 Company Information
9.3.2 Gaucher Disease (GD) Drugs Product Introduction
9.3.3 Pfizer (Protalix)
Gaucher Disease (GD) Drugs Sales Volume, Price, Sales Value and Gross Margin (2020-2022)
9.3.4 Contact Information
9.4 ISU ABXIS
9.4.1 Company Information
9.4.2 Gaucher Disease (GD) Drugs Product Introduction
9.4.3 ISU ABXIS
Gaucher Disease (GD) Drugs Sales Volume, Price, Sales Value and Gross Margin (2020-2022)
9.4.4 Contact Information
9.5 Actelion Pharma
9.5.1 Company Information
9.5.2 Gaucher Disease (GD) Drugs Product Introduction
9.5.3 Actelion Pharma
Gaucher Disease (GD) Drugs Sales Volume, Price, Sales Value and Gross Margin (2020-2022)
9.5.4 Contact Information
10 Conclusion
11 Methodology
1 Product Introduction and Overview
1.1 Product Definition
1.2 Product Specification
1.3 Global Market Overview
1.3.1 Global Gaucher Disease (GD) Drugs Market Status and Forecast (2017-2028)
1.3.2 Global Gaucher Disease (GD) Drugs Sales Value CAGR by Region
1.4 Market Drivers, Inhibitors
1.4.1 Market Drivers
1.4.2 Market Inhibitors
1.4.3 COVID-19 Impact Analysis
2 Global Gaucher Disease (GD) Drugs Supply by Company
2.1 Global Gaucher Disease (GD) Drugs Sales Volume by Company
2.2 Global Gaucher Disease (GD) Drugs Sales Value by Company
2.3 Global Gaucher Disease (GD) Drugs Price by Company
2.4 Gaucher Disease (GD) Drugs Production Location and Sales Area of Main Manufacturers
2.5 Trend of Concentration Rate
3 Global and Regional Gaucher Disease (GD) Drugs Market Status by Type
3.1 Gaucher Disease (GD) Drugs Type Introduction
3.1.1 Enzyme Replacement Therapy
3.1.2 Substrate Reduction Therapy
3.2 Global Gaucher Disease (GD) Drugs Market by Type
3.2.1 Global Gaucher Disease (GD) Drugs Sales Volume by Type (2017-2022)
3.2.2 Global Gaucher Disease (GD) Drugs Sales Value by Type (2017-2022)
3.2.3 Global Gaucher Disease (GD) Drugs Price by Type (2017-2022)
3.3 North America: by Type
3.4 Europe: by Type
3.5 China: by Type
3.6 Japan: by Type
3.7 Asia Other: by Type
4 Global and Regional Gaucher Disease (GD) Drugs Market Status by Application
4.1 Gaucher Disease (GD) Drugs Segment by Application
4.1.1 Non-neuronopathic Gaucher Disease
4.1.2 Neuronopathic Gaucher Disease
4.2 Global Gaucher Disease (GD) Drugs Market by Application
4.2.1 Global Gaucher Disease (GD) Drugs Sales Volume by Application (2017-2022)
4.2.2 Global Gaucher Disease (GD) Drugs Sales Value by Application (2017-2022)
4.2.3 Global Gaucher Disease (GD) Drugs Price by Application (2017-2022)
4.3 North America: by Application
4.4 Europe: by Application
4.5 China: by Application
4.6 Japan: by Application
4.7 Asia Other: by Application
5 Global Gaucher Disease (GD) Drugs Market Status by Region
5.1 Global Gaucher Disease (GD) Drugs Market by Region/Country
5.1.1 Global Gaucher Disease (GD) Drugs Sales Volume by Region/Country
5.1.2 Global Gaucher Disease (GD) Drugs Sales Value by Region/Country
5.2 North America Gaucher Disease (GD) Drugs Market Status
5.3 Europe Gaucher Disease (GD) Drugs Market Status
5.4 China Gaucher Disease (GD) Drugs Market Status
5.5 Japan Gaucher Disease (GD) Drugs Market Status
5.6 Asia Other Gaucher Disease (GD) Drugs Market Status
6 Sales Channel, Distributors and Buyers
6.1 Sales Channel
6.1.1 Direct Sales
6.1.2 Channel Sales
6.2 Gaucher Disease (GD) Drugs Distributors
6.3 Gaucher Disease (GD) Drugs Buyers
7 Global Gaucher Disease (GD) Drugs Market Forecast by Type and by Application
7.1 Global Gaucher Disease (GD) Drugs Sales Volume and Sales Value Forecast (2023-2028)
7.2 Global Gaucher Disease (GD) Drugs Forecast by Type
7.2.1 Global Gaucher Disease (GD) Drugs Sales Volume Forecast by Type
7.2.2 Global Gaucher Disease (GD) Drugs Sales Value Forecast by Type
7.2.3 Global Gaucher Disease (GD) Drugs Price Forecast by Type
7.3 Global Gaucher Disease (GD) Drugs Forecast by Application
7.3.1 Global Gaucher Disease (GD) Drugs Sales Volume Forecast by Application
7.3.2 Global Gaucher Disease (GD) Drugs Sales Value Forecast by Application
7.3.3 Global Gaucher Disease (GD) Drugs Price Forecast by Application
8 Global Gaucher Disease (GD) Drugs Market Forecast by Region/Country
8.1 Global Gaucher Disease (GD) Drugs Market Forecast by Region (2023-2028)
8.1.1 Global Gaucher Disease (GD) Drugs Sales Volume Forecast by Region (2023-2028)
8.1.2 Global Gaucher Disease (GD) Drugs Sales Value Forecast by Region (2023-2028)
8.2 North America Market Forecast
8.3 Europe Market Forecast
8.4 China Market Forecast
8.5 Japan Market Forecast
8.6 Asia Other Market Forecast
9 Key Participants Company Information
9.1 Shire
9.1.1 Company Information
9.1.2 Gaucher Disease (GD) Drugs Product Introduction
9.1.3 Shire
Gaucher Disease (GD) Drugs Sales Volume, Price, Sales Value and Gross Margin (2020-2022)
9.1.4 Contact Information
9.2 Sanofi
9.2.1 Company Information
9.2.2 Gaucher Disease (GD) Drugs Product Introduction
9.2.3 Sanofi
Gaucher Disease (GD) Drugs Sales Volume, Price, Sales Value and Gross Margin (2020-2022)
9.2.4 Contact Information
9.3 Pfizer (Protalix)
9.3.1 Company Information
9.3.2 Gaucher Disease (GD) Drugs Product Introduction
9.3.3 Pfizer (Protalix)
Gaucher Disease (GD) Drugs Sales Volume, Price, Sales Value and Gross Margin (2020-2022)
9.3.4 Contact Information
9.4 ISU ABXIS
9.4.1 Company Information
9.4.2 Gaucher Disease (GD) Drugs Product Introduction
9.4.3 ISU ABXIS
Gaucher Disease (GD) Drugs Sales Volume, Price, Sales Value and Gross Margin (2020-2022)
9.4.4 Contact Information
9.5 Actelion Pharma
9.5.1 Company Information
9.5.2 Gaucher Disease (GD) Drugs Product Introduction
9.5.3 Actelion Pharma
Gaucher Disease (GD) Drugs Sales Volume, Price, Sales Value and Gross Margin (2020-2022)
9.5.4 Contact Information
10 Conclusion
11 Methodology
no record found